707 related items for PubMed ID: 9476183
1. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A, Dattilo M.
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[Abstract] [Full Text] [Related]
2. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F, Goff J, Scowcroft C, Jennings D, Greski-Rose P.
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[Abstract] [Full Text] [Related]
3. Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
Swarbrick ET, Gough AL, Foster CS, Christian J, Garrett AD, Langworthy CH.
Eur J Gastroenterol Hepatol; 1996 May; 8(5):431-8. PubMed ID: 8804870
[Abstract] [Full Text] [Related]
4. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL, Huang B, Amer F, Christopoulos NG.
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[Abstract] [Full Text] [Related]
5. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T, Lemaire M, Agostini H.
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[Abstract] [Full Text] [Related]
6. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
Parente F, Bargiggia S, Bollani S, Colombo E, Bianchi Porro G.
Hepatogastroenterology; 1998 Jul; 45(22):990-3. PubMed ID: 9755995
[Abstract] [Full Text] [Related]
7. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
Lazzaroni M, Bargiggia S, Bianchi Porro G.
Am J Gastroenterol; 1997 Apr; 92(4):649-52. PubMed ID: 9128316
[Abstract] [Full Text] [Related]
8. The efficacy of the third pump inhibitor--pantoprazole--in the short-term treatment of Chinese patients with duodenal ulcer.
Chen TS, Chang FY, Ng WW, Lee FY, Hwang SJ, Lee SD.
Hepatogastroenterology; 1999 Apr; 46(28):2372-8. PubMed ID: 10522000
[Abstract] [Full Text] [Related]
9. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[Abstract] [Full Text] [Related]
10. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
Petite JP, Slama JL, Licht H, Lemerez M, Coste T, Andrieu J, Grimaud JC, Julien H, Dupuis J, Sallerin V.
Gastroenterol Clin Biol; 1993 Mar; 17(5):334-40. PubMed ID: 8349067
[Abstract] [Full Text] [Related]
11. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J.
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[Abstract] [Full Text] [Related]
12. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Buzás György M, Székely E, Illyés G, Széles I.
Orv Hetil; 2000 Jul 30; 141(31):1711-4. PubMed ID: 10976194
[Abstract] [Full Text] [Related]
13. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.
Hawkey CJ, Long RG, Bardhan KD, Wormsley KG, Cochran KM, Christian J, Moules IK.
Gut; 1993 Oct 30; 34(10):1458-62. PubMed ID: 8244121
[Abstract] [Full Text] [Related]
14. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole.
Londong W, Barth H, Dammann HG, Hengels KJ, Kleinert R, Müller P, Rohde H, Simon B.
Aliment Pharmacol Ther; 1991 Jun 30; 5(3):245-54. PubMed ID: 1888824
[Abstract] [Full Text] [Related]
15. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C.
Clin Ther; 1993 Jun 30; 15 Suppl B():14-21. PubMed ID: 7911399
[Abstract] [Full Text] [Related]
16. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
Earnest DL, Dorsch E, Jones J, Jennings DE, Greski-Rose PA.
Am J Gastroenterol; 1998 Feb 30; 93(2):238-43. PubMed ID: 9468251
[Abstract] [Full Text] [Related]
17. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ.
Am J Med; 2004 Jun 01; 116(11):740-8. PubMed ID: 15144910
[Abstract] [Full Text] [Related]
18. Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study.
Breiter JR, Riff D, Humphries TJ.
Am J Gastroenterol; 2000 Apr 01; 95(4):936-42. PubMed ID: 10763941
[Abstract] [Full Text] [Related]
19. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Yeomans ND, Tulassay Z, Juhász L, Rácz I, Howard JM, van Rensburg CJ, Swannell AJ, Hawkey CJ.
N Engl J Med; 1998 Mar 12; 338(11):719-26. PubMed ID: 9494148
[Abstract] [Full Text] [Related]
20. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
Am J Med; 2005 Nov 12; 118(11):1271-8. PubMed ID: 16271912
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
